<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37108249</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>11</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Plasma Exosomal Non-Coding RNA Profile Associated with Renal Damage Reveals Potential Therapeutic Targets in Lupus Nephritis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">7088</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24087088</ELocationID><Abstract><AbstractText>Despite considerable progress in our understanding of systemic lupus erythematosus (SLE) pathophysiology, patient diagnosis is often deficient and late, and this has an impact on disease progression. The aim of this study was to analyze non-coding RNA (ncRNA) packaged into exosomes by next-generation sequencing to assess the molecular profile associated with renal damage, one of the most serious complications of SLE, to identify new potential targets to improve disease diagnosis and management using Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. The plasma exosomes had a specific ncRNA profile associated with lupus nephritis (LN). The three ncRNA types with the highest number of differentially expressed transcripts were microRNAs (miRNAs), long non-coding RNAs (lncRNAs) and piwi-interacting RNAs (piRNAs). We identified an exosomal 29-ncRNA molecular signature, of which 15 were associated only with LN presence; piRNAs were the most representative, followed by lncRNAs and miRNAs. The transcriptional regulatory network showed a significant role for four lncRNAs (LINC01015, LINC01986, AC087257.1 and AC022596.1) and two miRNAs (miR-16-5p and miR-101-3p) in network organization, targeting critical pathways implicated in inflammation, fibrosis, epithelial-mesenchymal transition and actin cytoskeleton. From these, a handful of potential targets, such as transforming growth factor-&#x3b2; (TGF-&#x3b2;) superfamily binding proteins (activin-A, TGFB receptors, etc.), WNT/&#x3b2;-catenin and fibroblast growth factors (FGFs) have been identified for use as therapeutic targets of renal damage in SLE.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Flores-Chova</LastName><ForeName>Ana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1584-5490</Identifier><AffiliationInfo><Affiliation>Cardiometabolic and Renal Risk Research Group, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez-Arroyo</LastName><ForeName>Olga</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0001-9602-8419</Identifier><AffiliationInfo><Affiliation>Cardiometabolic and Renal Risk Research Group, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riffo-Campos</LastName><ForeName>Angela L</ForeName><Initials>AL</Initials><Identifier Source="ORCID">0000-0001-6300-3338</Identifier><AffiliationInfo><Affiliation>Millennium Nucleus on Sociomedicine (SocioMed) and Universidad de La Frontera, Doctorado en Ciencias Medicas, Temuco 4780000, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science, ETSE, University of Valencia, 46010 Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortega</LastName><ForeName>Ana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9763-0505</Identifier><AffiliationInfo><Affiliation>Cardiometabolic and Renal Risk Research Group, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBERCV (CIBER of Cardiovascular Diseases), 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forner</LastName><ForeName>Maria J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-6786-6760</Identifier><AffiliationInfo><Affiliation>Internal Medicine Unit, Hospital Clinico Universitario, 46010 Valencia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortes</LastName><ForeName>Raquel</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-9607-997X</Identifier><AffiliationInfo><Affiliation>Cardiometabolic and Renal Risk Research Group, INCLIVA Biomedical Research Institute, 46010 Valencia, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PI18/01405</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant><Grant><GrantID>PI21/00249</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant><Grant><GrantID>FI20/00096 and FI22/00032</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant><Grant><GrantID>(PID2020-117114GB-I00)</GrantID><Agency>Ministerio de Ciencia e Innovaci&#xf3;n</Agency><Country/></Grant><Grant><GrantID>N&#xba; ZA21-063</GrantID><Agency>Ministry of Universities of the Government of Spain</Agency><Country/></Grant><Grant><GrantID>NCS2021_013</GrantID><Agency>ANID-Millennium Science Initiative Program</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062085">RNA, Long Noncoding</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000094322">Piwi-Interacting RNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062085" MajorTopicYN="Y">RNA, Long Noncoding</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055354" MajorTopicYN="Y">Exosomes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094322" MajorTopicYN="N">Piwi-Interacting RNA</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RNA sequencing</Keyword><Keyword MajorTopicYN="N">bioinformatics enrichment analysis</Keyword><Keyword MajorTopicYN="N">exosomes</Keyword><Keyword MajorTopicYN="N">non-coding RNA</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>28</Day><Hour>1</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37108249</ArticleId><ArticleId IdType="pmc">PMC10139178</ArticleId><ArticleId IdType="doi">10.3390/ijms24087088</ArticleId><ArticleId IdType="pii">ijms24087088</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Beermann J., Piccoli M.T., Viereck J., Thum T. Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches. Physiol. Rev. 2016;96:1297&#x2013;1325. doi: 10.1152/physrev.00041.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00041.2015</ArticleId><ArticleId IdType="pubmed">27535639</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Hernandez J., Forner M.J., Pinto C., Chaves F.J., Cortes R., Redon J. Increased Urinary Exosomal MicroRNAs in Patients with Systemic Lupus Erythematosus. PLoS ONE. 2015;10:e0138618. doi: 10.1371/journal.pone.0138618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0138618</ArticleId><ArticleId IdType="pmc">PMC4577109</ArticleId><ArticleId IdType="pubmed">26390437</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes R., Forner M.J. Circular RNAS: Novel biomarkers of disease activity in systemic lupus erythematosus? Clin. Sci. 2019;133:1049&#x2013;1052. doi: 10.1042/CS20180826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20180826</ArticleId><ArticleId IdType="pubmed">31064795</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Hernandez J., Martinez-Arroyo O., Ortega A., Galera M., Solis-Salguero M.A., Chaves F.J., Redon J., Forner M.J., Cortes R. Urinary exosomal miR-146a as a marker of albuminuria, activity changes and disease flares in lupus nephritis. J. Nephrol. 2021;34:1157&#x2013;1167. doi: 10.1007/s40620-020-00832-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-020-00832-y</ArticleId><ArticleId IdType="pubmed">32803682</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W., Qiu J., Yin L., Hong X., Dai W., Tang D., Liu D., Dai Y. Integrated analysis of competing endogenous RNA networks in peripheral blood mononuclear cells of systemic lupus erythematosus. J. Transl. Med. 2021;19:362. doi: 10.1186/s12967-021-03033-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-03033-8</ArticleId><ArticleId IdType="pmc">PMC8380341</ArticleId><ArticleId IdType="pubmed">34419106</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye H., Wang X., Wang L., Chu X., Hu X., Sun L., Jiang M., Wang H., Wang Z., Zhao H., et al. Full high-throughput sequencing analysis of differences in expression profiles of long noncoding RNAs and their mechanisms of action in systemic lupus erythematosus. Arthritis Res. Ther. 2019;21:70. doi: 10.1186/s13075-019-1853-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-019-1853-7</ArticleId><ArticleId IdType="pmc">PMC6402184</ArticleId><ArticleId IdType="pubmed">30836987</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan X., Chen S., Shen R., Liu S., You Y. HOXA11-OS participates in lupus nephritis by targeting miR-124-3p mediating Cyr61 to regulate podocyte autophagy. Mol. Med. 2022;28:138. doi: 10.1186/s10020-022-00570-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-022-00570-w</ArticleId><ArticleId IdType="pmc">PMC9682779</ArticleId><ArticleId IdType="pubmed">36418932</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed R.F., Shaker O.G., Abdelghany H.M., Helmy Abdallah N., Elsayed S.H., Kamel B.A. Role of micro-RNA132 and its long non coding SOX2 in diagnosis of lupus nephritis. Lupus. 2022;31:89&#x2013;96. doi: 10.1177/09612033211067166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09612033211067166</ArticleId><ArticleId IdType="pubmed">35019799</ArticleId></ArticleIdList></Reference><Reference><Citation>Driedonks T.A.P., Nolte-&#x2019;t Hoen E.N.M. Circulating Y-RNAs in Extracellular Vesicles and Ribonucleoprotein Complexes; Implications for the Immune System. Front. Immunol. 2018;9:3164. doi: 10.3389/fimmu.2018.03164.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.03164</ArticleId><ArticleId IdType="pmc">PMC6340977</ArticleId><ArticleId IdType="pubmed">30697216</ArticleId></ArticleIdList></Reference><Reference><Citation>Boccitto M., Wolin S.L. Ro60 and Y RNAs: Structure, functions, and roles in autoimmunity. Crit. Rev. Biochem. Mol. Biol. 2019;54:133&#x2013;152. doi: 10.1080/10409238.2019.1608902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10409238.2019.1608902</ArticleId><ArticleId IdType="pmc">PMC6542706</ArticleId><ArticleId IdType="pubmed">31084369</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang P., Zhang X., Chen S., Tao Y., Ning M., Zhu Y., Liang J., Kong W., Shi B., Li Z., et al. A Novel Serum tsRNA for Diagnosis and Prediction of Nephritis in SLE. Front. Immunol. 2021;12:735105. doi: 10.3389/fimmu.2021.735105.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.735105</ArticleId><ArticleId IdType="pmc">PMC8632637</ArticleId><ArticleId IdType="pubmed">34867955</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Arroyo O., Ortega A., Redon J., Cortes R. Therapeutic Potential of Extracellular Vesicles in Hypertension-Associated Kidney Disease. Hypertension. 2021;77:28&#x2013;38. doi: 10.1161/HYPERTENSIONAHA.120.16064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.16064</ArticleId><ArticleId IdType="pubmed">33222549</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh T.X., Tan S.L., Roebuck M.M., Teo S.H., Kamarul T. A Systematic Review of Extracellular Vesicle-Derived Piwi-Interacting RNA in Human Body Fluid and Its Role in Disease Progression. Tissue Eng. Part. C Methods. 2022;28:511&#x2013;528. doi: 10.1089/ten.tec.2022.0092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ten.tec.2022.0092</ArticleId><ArticleId IdType="pubmed">35959742</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai C.Y., Hsieh S.C., Lu C.S., Wu T.H., Liao H.T., Wu C.H., Li K.J., Kuo Y.M., Lee H.T., Shen C.Y., et al. Cross-Talk between Mitochondrial Dysfunction-Provoked Oxidative Stress and Aberrant Noncoding RNA Expression in the Pathogenesis and Pathophysiology of SLE. Int. J. Mol. Sci. 2019;20:5183. doi: 10.3390/ijms20205183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20205183</ArticleId><ArticleId IdType="pmc">PMC6829370</ArticleId><ArticleId IdType="pubmed">31635056</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Arroyo O., Ortega A., Forner M.J., Cortes R. Mesenchymal Stem Cell-Derived Extracellular Vesicles as Non-Coding RNA Therapeutic Vehicles in Autoimmune Diseases. Pharmaceutics. 2022;14:733. doi: 10.3390/pharmaceutics14040733.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics14040733</ArticleId><ArticleId IdType="pmc">PMC9028692</ArticleId><ArticleId IdType="pubmed">35456567</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Vives E., Sole C., Moline T., Vidal M., Agraz I., Ordi-Ros J., Cortes-Hernandez J. The Urinary Exosomal miRNA Expression Profile is Predictive of Clinical Response in Lupus Nephritis. Int. J. Mol. Sci. 2020;21:1372. doi: 10.3390/ijms21041372.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21041372</ArticleId><ArticleId IdType="pmc">PMC7073236</ArticleId><ArticleId IdType="pubmed">32085620</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan L., Zhao M., Wu H., Zhang Y., Tong X., Gao L., Zhou L., Lu Q., Zeng J. Downregulated Serum Exosomal miR-451a Expression Correlates with Renal Damage and Its Intercellular Communication Role in Systemic Lupus Erythematosus. Front. Immunol. 2021;12:630112. doi: 10.3389/fimmu.2021.630112.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.630112</ArticleId><ArticleId IdType="pmc">PMC7906989</ArticleId><ArticleId IdType="pubmed">33643314</ArticleId></ArticleIdList></Reference><Reference><Citation>Vickers K.C., Palmisano B.T., Shoucri B.M., Shamburek R.D., Remaley A.T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 2011;13:423&#x2013;433. doi: 10.1038/ncb2210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2210</ArticleId><ArticleId IdType="pmc">PMC3074610</ArticleId><ArticleId IdType="pubmed">21423178</ArticleId></ArticleIdList></Reference><Reference><Citation>Villarroya-Beltri C., Gutierrez-Vazquez C., Sanchez-Cabo F., Perez-Hernandez D., Vazquez J., Martin-Cofreces N., Martinez-Herrera D.J., Pascual-Montano A., Mittelbrunn M., Sanchez-Madrid F. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat. Commun. 2013;4:2980. doi: 10.1038/ncomms3980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms3980</ArticleId><ArticleId IdType="pmc">PMC3905700</ArticleId><ArticleId IdType="pubmed">24356509</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Hernandez J., Riffo-Campos A.L., Ortega A., Martinez-Arroyo O., Perez-Gil D., Olivares D., Solaz E., Martinez F., Martinez-Hervas S., Chaves F.J., et al. Urinary- and Plasma-Derived Exosomes Reveal a Distinct MicroRNA Signature Associated with Albuminuria in Hypertension. Hypertension. 2021;77:960&#x2013;971. doi: 10.1161/HYPERTENSIONAHA.120.16598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.16598</ArticleId><ArticleId IdType="pubmed">33486986</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J.Y., Wang X.L., Yang Y.C., Zhang B., Wu Y.B. Upregulated miR-101 inhibits acute kidney injury-chronic kidney disease transition by regulating epithelial-mesenchymal transition. Hum. Exp. Toxicol. 2020;39:1628&#x2013;1638. doi: 10.1177/0960327120937334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0960327120937334</ArticleId><ArticleId IdType="pubmed">32633566</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Tao Y., Xie H., Liu C., Liu P. MicroRNA-101 inhibits renal tubular epithelial-to-mesenchymal transition by targeting TGF-beta1 type I receptor. Int. J. Mol. Med. 2021;47:119. doi: 10.3892/ijmm.2021.4952.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2021.4952</ArticleId><ArticleId IdType="pmc">PMC8099196</ArticleId><ArticleId IdType="pubmed">33955520</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X., Li S., Wang Z., Bai N., Feng Y. miR-101-3p negatively regulates inflammation in systemic lupus erythematosus via MAPK1 targeting and inhibition of the NF-kappaB pathway. Mol. Med. Rep. 2021;23:359. doi: 10.3892/mmr.2021.11998.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2021.11998</ArticleId><ArticleId IdType="pubmed">33760166</ArticleId></ArticleIdList></Reference><Reference><Citation>Connor K.L., Teenan O., Cairns C., Banwell V., Thomas R.A., Rodor J., Finnie S., Pius R., Tannahill G.M., Sahni V., et al. Identifying cell-enriched miRNAs in kidney injury and repair. JCI Insight. 2020;5:e140399. doi: 10.1172/jci.insight.140399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140399</ArticleId><ArticleId IdType="pmc">PMC7819746</ArticleId><ArticleId IdType="pubmed">33328386</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G., Zhang J., Liu D., Wei Q., Wang H., Lv Y., Ye Z., Liu G., Li L. Identification of Hub Genes and Potential ceRNA Networks of Diabetic Nephropathy by Weighted Gene Co-Expression Network Analysis. Front. Genet. 2021;12:767654. doi: 10.3389/fgene.2021.767654.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2021.767654</ArticleId><ArticleId IdType="pmc">PMC8591079</ArticleId><ArticleId IdType="pubmed">34790229</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamayo E., Alvarez P., Merino R. TGFbeta Superfamily Members as Regulators of B Cell Development and Function-Implications for Autoimmunity. Int. J. Mol. Sci. 2018;19:3928. doi: 10.3390/ijms19123928.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19123928</ArticleId><ArticleId IdType="pmc">PMC6321615</ArticleId><ArticleId IdType="pubmed">30544541</ArticleId></ArticleIdList></Reference><Reference><Citation>Morianos I., Papadopoulou G., Semitekolou M., Xanthou G. Activin-A in the regulation of immunity in health and disease. J. Autoimmun. 2019;104:102314. doi: 10.1016/j.jaut.2019.102314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.102314</ArticleId><ArticleId IdType="pubmed">31416681</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Gendi S.S., Moniem A.E., Tawfik N.M., Ashmawy M.M., Mohammed O.A., Mostafa A.K., Zakhari M.M., Herdan O.M. Value of serum and synovial fluid activin A and inhibin A in some rheumatic diseases. Int. J. Rheum. Dis. 2010;13:273&#x2013;279. doi: 10.1111/j.1756-185X.2010.01532.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1756-185X.2010.01532.x</ArticleId><ArticleId IdType="pubmed">20704626</ArticleId></ArticleIdList></Reference><Reference><Citation>Torricelli M., Bellisai F., Novembri R., Galeazzi L.R., Iuliano A., Voltolini C., Spreafico A., Galeazzi M., Petraglia F. High levels of maternal serum IL-17 and activin A in pregnant women affected by systemic lupus erythematosus. Am. J. Reprod. Immunol. 2011;66:84&#x2013;89. doi: 10.1111/j.1600-0897.2011.00978.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0897.2011.00978.x</ArticleId><ArticleId IdType="pubmed">21736662</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadiombo A.T., Maeshima A., Kayakabe K., Ikeuchi H., Sakairi T., Kaneko Y., Hiromura K., Nojima Y. Involvement of infiltrating macrophage-derived activin A in the progression of renal damage in MRL-lpr mice. Am. J. Physiol. Renal Physiol. 2017;312:F297&#x2013;F304. doi: 10.1152/ajprenal.00191.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00191.2016</ArticleId><ArticleId IdType="pubmed">27881396</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill G.S., Delahousse M., Nochy D., Mandet C., Bariety J. Proteinuria and tubulointerstitial lesions in lupus nephritis. Kidney Int. 2001;60:1893&#x2013;1903. doi: 10.1046/j.1523-1755.2001.00017.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-1755.2001.00017.x</ArticleId><ArticleId IdType="pubmed">11703608</ArticleId></ArticleIdList></Reference><Reference><Citation>Pamfil C., Makowska Z., De Groof A., Tilman G., Babaei S., Galant C., Montigny P., Demoulin N., Jadoul M., Aydin S., et al. Intrarenal activation of adaptive immune effectors is associated with tubular damage and impaired renal function in lupus nephritis. Ann. Rheum. Dis. 2018;77:1782&#x2013;1789. doi: 10.1136/annrheumdis-2018-213485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2018-213485</ArticleId><ArticleId IdType="pmc">PMC6241616</ArticleId><ArticleId IdType="pubmed">30065042</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal M., Bhattacharya S., Kalyan G., Hazra S. Cadherin profiling for therapeutic interventions in Epithelial Mesenchymal Transition (EMT) and tumorigenesis. Exp. Cell Res. 2018;368:137&#x2013;146. doi: 10.1016/j.yexcr.2018.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2018.04.014</ArticleId><ArticleId IdType="pubmed">29674112</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Du Y., Li K., Zhang W., Feng X., Hao J., Li H., Liu S. Anti-OSM Antibody Inhibits Tubulointerstitial Lesion in a Murine Model of Lupus Nephritis. Mediat. Inflamm. 2017;2017:3038514. doi: 10.1155/2017/3038514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/3038514</ArticleId><ArticleId IdType="pmc">PMC5463100</ArticleId><ArticleId IdType="pubmed">28626343</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu D., Senouthai S., Wang J., You Y. FKN Facilitates HK-2 Cell EMT and Tubulointerstitial Lesions via the Wnt/beta-Catenin Pathway in a Murine Model of Lupus Nephritis. Front. Immunol. 2019;10:784. doi: 10.3389/fimmu.2019.00784.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00784</ArticleId><ArticleId IdType="pmc">PMC6524725</ArticleId><ArticleId IdType="pubmed">31134047</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Liu J., Zhang X., Chen Q., Bai X., Hong X., Zhou L., Liu Y. Role of miRNA-671-5p in Mediating Wnt/beta-Catenin-Triggered Podocyte Injury. Front. Pharmacol. 2021;12:784489. doi: 10.3389/fphar.2021.784489.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.784489</ArticleId><ArticleId IdType="pmc">PMC8801877</ArticleId><ArticleId IdType="pubmed">35111054</ArticleId></ArticleIdList></Reference><Reference><Citation>Lennon R., Randles M.J., Humphries M.J. The importance of podocyte adhesion for a healthy glomerulus. Front. Endocrinol. 2014;5:160. doi: 10.3389/fendo.2014.00160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2014.00160</ArticleId><ArticleId IdType="pmc">PMC4196579</ArticleId><ArticleId IdType="pubmed">25352829</ArticleId></ArticleIdList></Reference><Reference><Citation>Asano-Matsuda K., Ibrahim S., Takano T., Matsuda J. Role of Rho GTPase Interacting Proteins in Subcellular Compartments of Podocytes. Int. J. Mol. Sci. 2021;22:3656. doi: 10.3390/ijms22073656.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22073656</ArticleId><ArticleId IdType="pmc">PMC8037304</ArticleId><ArticleId IdType="pubmed">33915776</ArticleId></ArticleIdList></Reference><Reference><Citation>Komiya Y., Onodera Y., Kuroiwa M., Nomimura S., Kubo Y., Nam J.M., Kajiwara K., Nada S., Oneyama C., Sabe H., et al. The Rho guanine nucleotide exchange factor ARHGEF5 promotes tumor malignancy via epithelial-mesenchymal transition. Oncogenesis. 2016;5:e258. doi: 10.1038/oncsis.2016.59.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/oncsis.2016.59</ArticleId><ArticleId IdType="pmc">PMC5047960</ArticleId><ArticleId IdType="pubmed">27617642</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogg M., Maier J.I., Van Wymersch C., Helmstadter M., Sammarco A., Lindenmeyer M., Zareba P., Montanez E., Walz G., Werner M., et al. alpha-Parvin Defines a Specific Integrin Adhesome to Maintain the Glomerular Filtration Barrier. J. Am. Soc. Nephrol. 2022;33:786&#x2013;808. doi: 10.1681/ASN.2021101319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2021101319</ArticleId><ArticleId IdType="pmc">PMC8970443</ArticleId><ArticleId IdType="pubmed">35260418</ArticleId></ArticleIdList></Reference><Reference><Citation>Takenawa T., Suetsugu S. The WASP-WAVE protein network: Connecting the membrane to the cytoskeleton. Nat. Rev. Mol. Cell Biol. 2007;8:37&#x2013;48. doi: 10.1038/nrm2069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2069</ArticleId><ArticleId IdType="pubmed">17183359</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki Y.W., Siomi M.C., Siomi H. PIWI-Interacting RNA: Its Biogenesis and Functions. Annu. Rev. Biochem. 2015;84:405&#x2013;433. doi: 10.1146/annurev-biochem-060614-034258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-060614-034258</ArticleId><ArticleId IdType="pubmed">25747396</ArticleId></ArticleIdList></Reference><Reference><Citation>Floege J., Barbour S.J., Cattran D.C., Hogan J.J., Nachman P.H., Tang S.C.W., Wetzels J.F.M., Cheung M., Wheeler D.C., Winkelmayer W.C., et al. Management and treatment of glomerular diseases (part 1): Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019;95:268&#x2013;280. doi: 10.1016/j.kint.2018.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2018.10.018</ArticleId><ArticleId IdType="pubmed">30665568</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovin B.H., Caster D.J., Cattran D.C., Gibson K.L., Hogan J.J., Moeller M.J., Roccatello D., Cheung M., Wheeler D.C., Winkelmayer W.C., et al. Management and treatment of glomerular diseases (part 2): Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019;95:281&#x2013;295. doi: 10.1016/j.kint.2018.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2018.11.008</ArticleId><ArticleId IdType="pubmed">30665569</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y., Smyth G.K., Shi W. featureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923&#x2013;930. doi: 10.1093/bioinformatics/btt656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt656</ArticleId><ArticleId IdType="pubmed">24227677</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A., Davis C.A., Schlesinger F., Drenkow J., Zaleski C., Jha S., Batut P., Chaisson M., Gingeras T.R. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15&#x2013;21. doi: 10.1093/bioinformatics/bts635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Love M.I., Huber W., Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. doi: 10.1186/s13059-014-0550-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukunaga T., Iwakiri J., Ono Y., Hamada M. LncRRIsearch: A Web Server for lncRNA-RNA Interaction Prediction Integrated With Tissue-Specific Expression and Subcellular Localization Data. Front. Genet. 2019;10:462. doi: 10.3389/fgene.2019.00462.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2019.00462</ArticleId><ArticleId IdType="pmc">PMC6546843</ArticleId><ArticleId IdType="pubmed">31191601</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y., Wang J., Jaehnig E.J., Shi Z., Zhang B. WebGestalt 2019: Gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 2019;47:W199&#x2013;W205. doi: 10.1093/nar/gkz401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz401</ArticleId><ArticleId IdType="pmc">PMC6602449</ArticleId><ArticleId IdType="pubmed">31114916</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498&#x2013;2504. doi: 10.1101/gr.1239303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.1239303</ArticleId><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>